BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative Employers
  Post Job | Search Resumes | Login

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

SanguiBioTech GmbH Sells First Quantity Of Anti-Cellulite Gel


10/19/2005 5:13:02 PM

WITTEN,Germany--(BUSINESS WIRE)--March 16, 2005--SanguiBioTech GmbH sold an initial quantity of its anti-cellulite gel to a German cosmetics distributor at a price of approximately $ 35,000. The distributor intends to offer the preparation in German TV shop programmes under his own brand name. Sales are expected to commence early/mid April. Sangui's anti-cellulite-gel obtained premium results in recent tests with several groups of probands carried out by Dermatest, a renowned independent cosmetics research institute headquartered in Muenster, Germany. Skin elasticity improved over 40% in average in four weeks treatments and up to 61,5% in longer term treatments.

Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES